|Bid||106.60 x 900|
|Ask||106.62 x 800|
|Day's Range||104.88 - 107.02|
|52 Week Range||68.53 - 107.15|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||174.64|
|Earnings Date||Jan 31, 2024 - Feb 05, 2024|
|Forward Dividend & Yield||2.00 (1.90%)|
|Ex-Dividend Date||Dec 29, 2023|
|1y Target Est||108.75|
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inari Medical's (NARI) latest announcement of first patient enrollment in PEERLESS II RCT is likely to aid in changing guidelines in treating intermediate-risk PE patients globally.
In the realm of stock market movements, insider trading activity is often a significant indicator for investors.